| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.004 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.4 | 0.007 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |